Med Encentive entered the industry of Medical Research in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417115, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact James Dempster, Executive by calling (405) 319-8450 during business hours. You can also write to the business’ Single Location at 800 Research Parkway, Oklahoma City, Oklahoma OK 73104. You can also visit the company’s website at medencentive.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Med Encentive |
| Representative: | James Dempster, Executive |
| Place of Business: | 800 Research Parkway, Oklahoma City, OK 73104 |
| Contact Number: | (405) 319-8450 |
| Website: | medencentive.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 5417115 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2005 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Med Encentive is a company operating from Oklahoma, Oklahoma providing professional Medical Research and relevant B2B variables. It was founded in 2005 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417115 as Medical Research.
With a current employee count of 1 to 4, Med Encentive has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative James Dempster, Executive at (405) 319-8450 for related queries, or to locate its Single Location using the coordinates 35.47514,-97.50355.
The Single Location can also be found at the street address 800 Research Parkway in Oklahoma City, Oklahoma 73104 and can be engaged online through the company website at medencentive.com, the company Twitter , and Facebook page .